Your session is about to expire
← Back to Search
Device
Eye4 for Low Vision (DRTARES Trial)
N/A
Waitlist Available
Led By Mitul Mehta, MD
Research Sponsored by Eyedaptic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
DRTARES Trial Summary
This trial will test whether an augmented reality visual aid can help improve the vision of people with diabetic retinopathy.
Eligible Conditions
- Low Vision
- Diabetic Retinopathy
DRTARES Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Visual acuity at distance
Secondary outcome measures
Contrast sensitivity
Visual acuity at near
DRTARES Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Eye4Experimental Treatment1 Intervention
This is the arm with the Eyedaptic Device
Group II: BaselinePlacebo Group1 Intervention
This is the placebo arm with the best correction the subject has
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eye4
2022
N/A
~20
Find a Location
Who is running the clinical trial?
EyedapticLead Sponsor
Mitul Mehta, MDPrincipal InvestigatorEyedaptic
1 Previous Clinical Trials
30 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger